Post job

Cureatr CEO and executives

Executive Summary. Based on our data team's research, Richard Resnick is the Cureatr's CEO. Cureatr has 42 employees, of which 13 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Cureatr executive team is 15% female and 85% male.
  • 65% of the management team is White.
  • 9% of Cureatr management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Cureatr?
Share your experience

Rate Cureatr's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Richard Resnick

CEO

Richard Resnick's LinkedIn

I bring a proven record of success in HCIT and Life Science B2B software and service environments to create/ partner/acquire market-leading products that maximize EBITDA and shareholder equity. Armed with an MBA from MIT and multiple degrees in computer science, for over 20 years I have delivered impressive outcomes for venture capital-backed SaaS companies, attracted top talent, influenced market behavior, and closed win-win deals that accelerated P&L growth. ENTREPRENEURIAL, VISIONARY CEO: My deep technology and product management expertise combined with executive experience navigating early to mid-stage companies through successful outcomes guide me in both tactical and strategic leadership. I am proud of my ability to 1) develop strategy based on current reality and aligning teams to deliver sustainable growth, 2) boost market visibility and attract multiple buyers through persuasive communication style, entrepreneurial mindset and technical thought leadership (see TED talk on Genomic Revolution).DRIVE CULTURE TRANSFORMATION: I invest considerable time creating an authentic and transparent culture while ensuring strategy is clearly understood and bought into. I love instilling a purpose in teams based on a transparent assessment of where we are, why we’re there, where we’re going, and why we’re going there. The biggest compliment you can give me is, ‘you helped me succeed.’ DELIVER RESULTS: By leveraging an insightful understanding of technology, strategy, competitive forces, product positioning, and high-performing teams, I have consistently optimized revenue growth and profitability. As the CEO of GQ Life Sciences, revitalized strategy to turn company around from a -44% to a 33% EBITDA margin and sold company for 10X EBITDA through competitive bidding process in October 2016. I am currently the CEO of Cureatr where we are posting a double-digit YoY growth in the medication software/data industry. To discuss opportunities: rjr@sloan.mit.edu

Greg Downing

Board Member

Alex Khomenko

CTO, Co-Founder

Alex Khomenko's LinkedIn

CTO/co-founder @ Cureatr. Past: 1st developer, director of engineering, social media @ 23andMe; architect @ PayPal.

Joseph Mayer

Founder

Dana Barrett

Vice President of Human Resources

Matthew Benedon

Vice President of Corporate Development and Partnerships

Morgan Beschle

Chief Product Officer

Rob Dilling

Chief Financial Officer

Zarah Mayewski

James Jim

Board Member

Do you work at Cureatr?

Does the leadership team provide a clear direction for Cureatr?

Cureatr jobs

Cureatr founders

Name & TitleBio
Greg Downing

Board Member

Alex Khomenko

CTO, Co-Founder

Alex Khomenko's LinkedIn

CTO/co-founder @ Cureatr. Past: 1st developer, director of engineering, social media @ 23andMe; architect @ PayPal.

Joseph Mayer

Founder

Cureatr board members

Name & TitleBio
Richard Resnick

CEO

Richard Resnick's LinkedIn

I bring a proven record of success in HCIT and Life Science B2B software and service environments to create/ partner/acquire market-leading products that maximize EBITDA and shareholder equity. Armed with an MBA from MIT and multiple degrees in computer science, for over 20 years I have delivered impressive outcomes for venture capital-backed SaaS companies, attracted top talent, influenced market behavior, and closed win-win deals that accelerated P&L growth. ENTREPRENEURIAL, VISIONARY CEO: My deep technology and product management expertise combined with executive experience navigating early to mid-stage companies through successful outcomes guide me in both tactical and strategic leadership. I am proud of my ability to 1) develop strategy based on current reality and aligning teams to deliver sustainable growth, 2) boost market visibility and attract multiple buyers through persuasive communication style, entrepreneurial mindset and technical thought leadership (see TED talk on Genomic Revolution).DRIVE CULTURE TRANSFORMATION: I invest considerable time creating an authentic and transparent culture while ensuring strategy is clearly understood and bought into. I love instilling a purpose in teams based on a transparent assessment of where we are, why we’re there, where we’re going, and why we’re going there. The biggest compliment you can give me is, ‘you helped me succeed.’ DELIVER RESULTS: By leveraging an insightful understanding of technology, strategy, competitive forces, product positioning, and high-performing teams, I have consistently optimized revenue growth and profitability. As the CEO of GQ Life Sciences, revitalized strategy to turn company around from a -44% to a 33% EBITDA margin and sold company for 10X EBITDA through competitive bidding process in October 2016. I am currently the CEO of Cureatr where we are posting a double-digit YoY growth in the medication software/data industry. To discuss opportunities: rjr@sloan.mit.edu

Greg Downing

Board Member

James Jim

Board Member

John Clarke

Board Member

William Winkenwerder

Board Member

Cureatr executives FAQs

Cureatr highest paying jobs

Zippia gives an in-depth look into the details of Cureatr, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cureatr. The employee data is based on information from people who have self-reported their past or current employments at Cureatr. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cureatr. The data presented on this page does not represent the view of Cureatr and its employees or that of Zippia.

Cureatr may also be known as or be related to Cureatr, Cureatr Inc. and Cureatr, Inc.